- Home
- ABVX vs VINP Comparison
ABVX vs VINP Comparison
Compare ABVX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- VINP
- Stock Information
- Founded
- ABVX 2013
- VINP 2009
- Country
- ABVX France
- VINP Brazil
- Employees
- ABVX N/A
- VINP N/A
- Industry
- ABVX
- VINP Investment Managers
- Sector
- ABVX
- VINP Finance
- Exchange
- ABVX Nasdaq
- VINP Nasdaq
- Market Cap
- ABVX 722.3M
- VINP 641.7M
- IPO Year
- ABVX N/A
- VINP 2021
- Fundamental
- Price
- ABVX $8.08
- VINP $10.11
- Analyst Decision
- ABVX Strong Buy
- VINP Strong Buy
- Analyst Count
- ABVX 7
- VINP 2
- Target Price
- ABVX $37.86
- VINP $13.50
- AVG Volume (30 Days)
- ABVX 162.8K
- VINP 64.8K
- Earning Date
- ABVX 03-24-2025
- VINP 02-26-2025
- Dividend Yield
- ABVX N/A
- VINP 6.92%
- EPS Growth
- ABVX N/A
- VINP N/A
- EPS
- ABVX N/A
- VINP 0.60
- Revenue
- ABVX $9,676,417.00
- VINP $88,217,697.00
- Revenue This Year
- ABVX $31.67
- VINP $17.69
- Revenue Next Year
- ABVX $759.77
- VINP $50.55
- P/E Ratio
- ABVX N/A
- VINP $16.90
- Revenue Growth
- ABVX 100.87
- VINP 9.03
- 52 Week Low
- ABVX $5.50
- VINP $9.01
- 52 Week High
- ABVX $17.02
- VINP $11.85
- Technical
- Relative Strength Index (RSI)
- ABVX 75.42
- VINP 44.04
- Support Level
- ABVX $5.88
- VINP $10.42
- Resistance Level
- ABVX $7.57
- VINP $10.86
- Average True Range (ATR)
- ABVX 0.46
- VINP 0.21
- MACD
- ABVX 0.24
- VINP -0.03
- Stochastic Oscillator
- ABVX 97.68
- VINP 12.87
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.